Search
forResearch 10 of 219
- Proceedings of the Heinz Maurer-Symposium “Review and Preview in Science for Healthy Skin” June 28th 2014, Jakobsberg, Boppard, Germany
- Which is the ideal JAK inhibitor for alopecia areata – Baricitinib, tofacitinib, ritlecitinib or ifidancitinib - Revisiting the immunomechanisms of the JAK pathway
- Role of janus kinase inhibitors in the treatment of alopecia areata
- The role of Janus kinase inhibitors in the treatment of alopecia areata: A systematic review
- The Relative Efficacy and Safety of Monotherapies for Alopecia Areata: A Network Meta‐Analysis Study
- A review of Janus kinase inhibitor use in scarring alopecia
- Short-term malignancy risk of JAK inhibitors in severe alopecia areata: a multicenter cohort study
- 77200 Infections and Therapy Lapses Predominate as Flare Triggers on Oral JAK Inhibitors for Alopecia Areata: A Retrospective Cohort Study
- 73571 The real-world impact of JAK inhibitor treatment on anxiety and depression outcomes and the role of eyebrow and eyelash hair regrowth in alopecia areata: TARGET-DERM
- Combined Low Dose Oral Minoxidil and Immunomodulator Efficacy and Safety in Alopecia Areata: A Systematic Review
Learn
— no results
Try a deeper search in learn →Community
— no results
Try a deeper search in community →